Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization Sort ascending
Sep
26
2017
Digital Health Checkup (Part Two): Key Commercial Questions When Contracting for Digital Health Solutions Covington & Burling LLP
Sep
2
2014
EU Court Of Justice Further Clarifies Definition Of Medicinal Products – And Raises New Questions Covington & Burling LLP
Oct
26
2017
Practical Considerations for Device Industry Policyholders Experiencing Puerto Rico Hurricane Losses Covington & Burling LLP
Oct
11
2014
Pharmaceutical Research and Manufacturers of America (PhRMA) Filed Suit Today Seeking to Invalidate the 340B Orphan Drug Exclusion Interpretative Rule Covington & Burling LLP
Nov
18
2014
The Republican Senate Take-Over: Implications for the Affordable Care Act Covington & Burling LLP
Nov
21
2014
The Supreme Court and the Affordable Care Act: Round Two Covington & Burling LLP
Dec
2
2014
HHS Releases Guidance Regarding Application of HIPAA Privacy Rule in Emergency Situations Covington & Burling LLP
Dec
18
2014
Indonesia — Can it Unleash Needed Investment? Covington & Burling LLP
Jan
13
2015
CDRH Releases 2015 Guidance Document Agenda, Announces Retrospective Guidance Document Review -- Center for Devices and Radiological Health Covington & Burling LLP
Jan
15
2015
JP Morgan Conference Highlights eHealth Technologies, Data-Driven Therapeutics Covington & Burling LLP
Feb
2
2015
EMA Transparency Policy – EMA Launches Public Consultation On The Publication Of Information Under The New EU Clinical Trials Regulation Covington & Burling LLP
Mar
31
2015
HHS Creates A New Out-of-Pocket Limit For Health Plans: Health and Human Services Covington & Burling LLP
Apr
3
2015
CMS Releases Proposed Rules for Stage 3 of EHR’s Meaningful Use Program Covington & Burling LLP
Apr
7
2015
CMS Releases New Reimbursement Guidance for Biosimilars Covington & Burling LLP
Apr
29
2015
HIPAA Settlement Follows Unsecured Paper Records Disposal Covington & Burling LLP
Jun
11
2015
CMS Releases Additional Medicare Data; Expands Access to Data for “Commercial” Purposes Covington & Burling LLP
Mar
13
2018
Trump Administration Proposes Rules to Expand Access to Short-term Health Plans Covington & Burling LLP
Aug
3
2015
21st Century Cures Act Passes the House: Contains Key Provisions Related to Medical Devices Covington & Burling LLP
Apr
27
2018
The Week Ahead in the European Parliament – April 27, 2018 Covington & Burling LLP
Sep
17
2018
ICO consults on privacy “regulatory sandbox” Covington & Burling LLP
May
13
2016
Transparency and Conflicts of Interest: France Heading Towards Additional Healthcare Reforms Covington & Burling LLP
May
23
2016
First European Commission Borderline Decision: Does it Answer or Raise Questions? Covington & Burling LLP
Jul
28
2016
ONC Report to Congress Identifies Gaps in Oversight of Privacy and Security of mHealth Technologies and Health Social Media Covington & Burling LLP
Oct
9
2016
District Court Dismisses State Law Unfair Competition Claim as Preempted by Federal Copyright and Patent Law Covington & Burling LLP
Nov
4
2016
New Developments in Implementation of Interstate Medical Licensure Compact (IMLC) Covington & Burling LLP
Dec
2
2016
Senate Unanimously Passes the ECHO Act Covington & Burling LLP
Aug
5
2014
Summary Of FDA Advertising and Promotion Enforcement Activities Covington & Burling LLP
Aug
25
2014
FDA’s Announced Framework for Regulating Laboratory Developed Tests (LDTs) Leaves Open Many Questions Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins